Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections

M. J. Hepner, D. R. Ownby, J. A. Anderson, M. S. Rowe, D. Sears-Ewald, E. B. Brown

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

To learn whether patients taking beta-blocker (BB) drugs were at increased risk of having systemic reactions (SRs) from allergen immunotherapy, we prospectively studied 56,105 injection visits in 3178 patients during a 1-year interval. A total of 166 SRs occurred in 144 patients (4.5% of all patients) or 3.0 SRs occurred per 1000 injection visits. Sixty-eight patients were taking BB drugs throughout the year, and only one patient had an SR. By chance, 3.08 patients were expected to have had SRs. We conclude that BB drugs did not increase the frequency of SRs in teh patients studied who were receiving immunotherapy (p>0.95). Patients taking BB drugs may still be at increased risk, however, from more severe SRs or their SRs may be more refractory to therapy.

Original languageEnglish (US)
Pages (from-to)407-411
Number of pages5
JournalThe Journal of Allergy and Clinical Immunology
Volume86
Issue number3 PART 1
DOIs
StatePublished - Sep 1990

Fingerprint

Immunologic Desensitization
Injections
Pharmaceutical Preparations
Immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. / Hepner, M. J.; Ownby, D. R.; Anderson, J. A.; Rowe, M. S.; Sears-Ewald, D.; Brown, E. B.

In: The Journal of Allergy and Clinical Immunology, Vol. 86, No. 3 PART 1, 09.1990, p. 407-411.

Research output: Contribution to journalArticle

Hepner, M. J. ; Ownby, D. R. ; Anderson, J. A. ; Rowe, M. S. ; Sears-Ewald, D. ; Brown, E. B. / Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. In: The Journal of Allergy and Clinical Immunology. 1990 ; Vol. 86, No. 3 PART 1. pp. 407-411.
@article{25a422a38c2348dc8ae194fef2d3d787,
title = "Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections",
abstract = "To learn whether patients taking beta-blocker (BB) drugs were at increased risk of having systemic reactions (SRs) from allergen immunotherapy, we prospectively studied 56,105 injection visits in 3178 patients during a 1-year interval. A total of 166 SRs occurred in 144 patients (4.5{\%} of all patients) or 3.0 SRs occurred per 1000 injection visits. Sixty-eight patients were taking BB drugs throughout the year, and only one patient had an SR. By chance, 3.08 patients were expected to have had SRs. We conclude that BB drugs did not increase the frequency of SRs in teh patients studied who were receiving immunotherapy (p>0.95). Patients taking BB drugs may still be at increased risk, however, from more severe SRs or their SRs may be more refractory to therapy.",
author = "Hepner, {M. J.} and Ownby, {D. R.} and Anderson, {J. A.} and Rowe, {M. S.} and D. Sears-Ewald and Brown, {E. B.}",
year = "1990",
month = "9",
doi = "10.1016/S0091-6749(05)80105-8",
language = "English (US)",
volume = "86",
pages = "407--411",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3 PART 1",

}

TY - JOUR

T1 - Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections

AU - Hepner, M. J.

AU - Ownby, D. R.

AU - Anderson, J. A.

AU - Rowe, M. S.

AU - Sears-Ewald, D.

AU - Brown, E. B.

PY - 1990/9

Y1 - 1990/9

N2 - To learn whether patients taking beta-blocker (BB) drugs were at increased risk of having systemic reactions (SRs) from allergen immunotherapy, we prospectively studied 56,105 injection visits in 3178 patients during a 1-year interval. A total of 166 SRs occurred in 144 patients (4.5% of all patients) or 3.0 SRs occurred per 1000 injection visits. Sixty-eight patients were taking BB drugs throughout the year, and only one patient had an SR. By chance, 3.08 patients were expected to have had SRs. We conclude that BB drugs did not increase the frequency of SRs in teh patients studied who were receiving immunotherapy (p>0.95). Patients taking BB drugs may still be at increased risk, however, from more severe SRs or their SRs may be more refractory to therapy.

AB - To learn whether patients taking beta-blocker (BB) drugs were at increased risk of having systemic reactions (SRs) from allergen immunotherapy, we prospectively studied 56,105 injection visits in 3178 patients during a 1-year interval. A total of 166 SRs occurred in 144 patients (4.5% of all patients) or 3.0 SRs occurred per 1000 injection visits. Sixty-eight patients were taking BB drugs throughout the year, and only one patient had an SR. By chance, 3.08 patients were expected to have had SRs. We conclude that BB drugs did not increase the frequency of SRs in teh patients studied who were receiving immunotherapy (p>0.95). Patients taking BB drugs may still be at increased risk, however, from more severe SRs or their SRs may be more refractory to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0024995754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024995754&partnerID=8YFLogxK

U2 - 10.1016/S0091-6749(05)80105-8

DO - 10.1016/S0091-6749(05)80105-8

M3 - Article

C2 - 1976666

AN - SCOPUS:0024995754

VL - 86

SP - 407

EP - 411

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3 PART 1

ER -